Synthesis and discovery of ω-3 polyunsaturated fatty acid- alkanolamine (PUFA-AA) derivatives as anti-inflammatory agents targeting Nur77

Bioorg Chem. 2020 Dec:105:104456. doi: 10.1016/j.bioorg.2020.104456. Epub 2020 Nov 8.

Abstract

In this work, three series of ω-3 polyunsaturated fatty acid-alkanolamine derivatives (PUFA-AAs) were synthesized, characterized and their anti-inflammatory activity in vivo was evaluated. Compounds 4a, 4f, and 4k exhibited marked anti-inflammatory activity in LPS-stimulated RAW 264.7 cells. The most promising compound 4k dose-dependently suppressed the cytokines with IC50 values in the low micromolar range. Further, 4k exhibited potential in vitro Nur77-binding affinity (Kd = 6.99 × 10-6 M) which is consistent with the result of docking studies. Next, the anti-inflammatory mechanism of 4k was found to be through NF-κB signal pathway in a Nur77-dependent manner. Moreover, we also observed 4k significantly inhibited LPS-induced expression of cytokines (IL-6, TNF-α, and IL-1β) through suppressing NF-κB activation and attenuated LPS-induced inflammation in mouse acute lung injury (ALI) model. In conclusion, the study strongly suggests that the PUFA-AA derivatives can be particularly as new Nur77 mediators for further treatment in inflammatory diseases.

Keywords: Acute lung injury; Anti-inflammatory activity; Molecular docking; Nur77; ω-3 polyunsaturated fatty acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amines / chemistry*
  • Animals
  • Anti-Inflammatory Agents / chemical synthesis*
  • Anti-Inflammatory Agents / pharmacology
  • Cytokines / metabolism
  • Disease Models, Animal
  • Drug Design
  • Enzyme Activation / drug effects
  • Fatty Acids, Unsaturated / chemical synthesis*
  • Fatty Acids, Unsaturated / pharmacology
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Molecular Docking Simulation
  • NF-kappa B / metabolism
  • Nuclear Receptor Subfamily 4, Group A, Member 1 / metabolism*
  • RAW 264.7 Cells
  • Signal Transduction

Substances

  • Amines
  • Anti-Inflammatory Agents
  • Cytokines
  • Fatty Acids, Unsaturated
  • NF-kappa B
  • Nuclear Receptor Subfamily 4, Group A, Member 1